Get started
Author

Adam Carie

Observed names: A E Carie, Adam Carie (20374738), Adam E. Carie, Carie, Adam
Observed institutions: Texas Biomedical Research Institute, University of South Florida, Moffitt Cancer Center, Yale University, Intezyne (United States), Marshall University
ORCID: 0009-0005-7488-4667
Observed ORCIDs: 0009-0005-7488-4667, 0000-0001-7804-0465
OpenAlex ID: A5087620519
Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors
2005 · Jiazhi Sun, De-an Wang, et al. · Oncogene · 108
A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway
2007 · A E Carie, S M Sebti · Oncogene · 80
Blockade of Protein Geranylgeranylation Inhibits Cdk2-Dependent p27Kip1 Phosphorylation on Thr187 and Accumulates p27Kip1 in the Nucleus: Implications for Breast Cancer Therapy
2009 · Aslamuzzaman Kazi, Adam Carie, et al. · Molecular and Cellular Biology · 66
A Versatile Polymer Micelle Drug Delivery System for Encapsulation and In Vivo Stabilization of Hydrophobic Anticancer Drugs
2012 · Jonathan Rios-Doria, Adam Carie, et al. · Journal of Drug Delivery · 53
PDF
Structure–activity studies on a library of potent calix[4]arene-based PDGF antagonists that inhibit PDGF-stimulated PDGFR tyrosine phosphorylation
2006 · Huchen Zhou, De-an Wang, et al. · Organic & Biomolecular Chemistry · 52
A Small Molecule Disruptor of Rb/Raf-1 Interaction Inhibits Cell Proliferation, Angiogenesis, and Growth of Human Tumor Xenografts in Nude Mice
2008 · Rebecca Kinkade, Piyali Dasgupta, et al. · Cancer Research · 48
PDF
Synthesis and Characterization of Micelle-Forming PEG-Poly(Amino Acid) Copolymers with Iron-Hydroxamate Cross-Linkable Blocks for Encapsulation and Release of Hydrophobic Drugs
2017 · Kevin N. Sill, Bradford Sullivan, et al. · Biomacromolecules · 46
PDF
Development and in Vivo Quantitative Magnetic Resonance Imaging of Polymer Micelles Targeted to the Melanocortin 1 Receptor
2013 · Natalie M. Barkey, Christian Preihs, et al. · Journal of Medicinal Chemistry · 27
IT-141, a Polymer Micelle Encapsulating SN-38, Induces Tumor Regression in Multiple Colorectal Cancer Models
2011 · Adam Carie, Jonathan Rios-Doria, et al. · Journal of Drug Delivery · 27
PDF
Imaging the delivery of drug-loaded, iron-stabilized micelles
2017 · Suzanne J. Bakewell, Adam Carie, et al. · Nanomedicine Nanotechnology Biology and Medicine · 25
PDF
Ruthenium Drug BOLD-100 Regulates BRAF MT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation
2024 · Daryl Griffin, Robbie Carson, et al. · Molecular Cancer Research · 14
IT-143, A Polymer Micelle Nanoparticle, Widens Therapeutic Window of Daunorubicin
2016 · Tara Lee Costich, Adam Carie, et al. · Pharmaceutical Nanotechnology · 10
Stabilized Polymer Micelles for the Development of IT-147, an Epothilone D Drug-Loaded Formulation
2016 · Adam Carie, Bradford Sullivan, et al. · Journal of Drug Delivery · 7
PDF
Abstract 1183: Targeting the DNA repair pathway with BOLD-100 in BRAF mutant colorectal cancer
2021 · Robbie Carson, Shivaali Karelia, et al. · Cancer Research · 2
Table S2 from Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation
2024 · Daryl Griffin, Robbie Carson, et al. · 1
Abstract 1321: IT-147: A stabilized polymer micelle formulation of epothilone D for treatment of solid tumors
2016 · Adam Carie, Taylor Buley, et al. · Cancer Research · 1
Supplementary Figure 2 from Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation
2026 · Daryl Griffin, Robbie Carson, et al.
Supplementary Figure 1 from Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation
2026 · Daryl Griffin, Robbie Carson, et al.
Table S4 from Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation
2026 · Daryl Griffin, Robbie Carson, et al.
Supplementary Figure 5 from Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation
2026 · Daryl Griffin, Robbie Carson, et al.
Table S3 from Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation
2026 · Daryl Griffin, Robbie Carson, et al.
Supplementary Figure 3 from Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation
2026 · Daryl Griffin, Robbie Carson, et al.
Table S2 from Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation
2026 · Daryl Griffin, Robbie Carson, et al.
Table S5 from Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation
2026 · Daryl Griffin, Robbie Carson, et al.
Table S1 from Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation
2026 · Daryl Griffin, Robbie Carson, et al.
Works count: 60
Citation count: 567
H-index: 11
I10-index: 12
Year
Topic
Type